Sanara MedTech Inc. (SMTI)
USD 31.79
(-6.47%)
USD 31.79
(-6.47%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 4.71 Million USD | 32.93% |
| 2022 | 3.54 Million USD | 73.27% |
| 2021 | 2.04 Million USD | 78.37% |
| 2020 | 1.14 Million USD | 53.81% |
| 2019 | 746.51 Thousand USD | 60.43% |
| 2018 | 465.31 Thousand USD | -34.59% |
| 2017 | 711.39 Thousand USD | 104.16% |
| 2016 | 348.45 Thousand USD | -14.96% |
| 2015 | 409.77 Thousand USD | 1.8% |
| 2014 | 402.53 Thousand USD | 30.9% |
| 2013 | 307.5 Thousand USD | -32.3% |
| 2012 | 454.21 Thousand USD | 67.48% |
| 2011 | 271.2 Thousand USD | -6.49% |
| 2010 | 290.03 Thousand USD | 121.96% |
| 2009 | 130.66 Thousand USD | 30.85% |
| 2008 | 99.85 Thousand USD | -62.07% |
| 2007 | 263.27 Thousand USD | 172.62% |
| 2006 | 96.57 Thousand USD | 215.14% |
| 2005 | 30.64 Thousand USD | -67.84% |
| 2004 | 95.3 Thousand USD | 0.0% |
| 2001 | 131.74 Thousand USD | 0.0% |
| 2000 | - USD | 0.0% |
| 1999 | - USD | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | 4.22 Million USD | -10.35% |
| 2024 Q2 | 3.56 Million USD | -15.71% |
| 2023 Q2 | 4.42 Million USD | 28.82% |
| 2023 FY | 4.71 Million USD | 32.93% |
| 2023 Q4 | 4.71 Million USD | -6.04% |
| 2023 Q3 | 5.02 Million USD | 13.58% |
| 2023 Q1 | 3.43 Million USD | -3.31% |
| 2022 FY | 3.54 Million USD | 73.27% |
| 2022 Q1 | 2.17 Million USD | 6.01% |
| 2022 Q2 | 2.31 Million USD | 6.49% |
| 2022 Q3 | 3.73 Million USD | 61.5% |
| 2022 Q4 | 3.54 Million USD | -4.96% |
| 2021 FY | 2.04 Million USD | 78.37% |
| 2021 Q1 | 1.17 Million USD | 2.67% |
| 2021 Q2 | 1.53 Million USD | 30.5% |
| 2021 Q4 | 2.04 Million USD | 31.94% |
| 2021 Q3 | 1.55 Million USD | 0.91% |
| 2020 FY | 1.14 Million USD | 53.81% |
| 2020 Q1 | 1 Million USD | 35.19% |
| 2020 Q2 | 862.69 Thousand USD | -14.52% |
| 2020 Q3 | 787.82 Thousand USD | -8.68% |
| 2020 Q4 | 1.14 Million USD | 45.75% |
| 2019 Q4 | 746.51 Thousand USD | -6.66% |
| 2019 Q1 | 345.96 Thousand USD | -25.65% |
| 2019 Q3 | 799.81 Thousand USD | 102.7% |
| 2019 Q2 | 394.58 Thousand USD | 14.06% |
| 2019 FY | 746.51 Thousand USD | 60.43% |
| 2018 Q1 | 613.71 Thousand USD | -13.73% |
| 2018 Q3 | - USD | -100.0% |
| 2018 Q4 | 465.31 Thousand USD | 0.0% |
| 2018 FY | 465.31 Thousand USD | -34.59% |
| 2018 Q2 | 494.55 Thousand USD | -19.42% |
| 2017 Q2 | 455.3 Thousand USD | 50.86% |
| 2017 Q3 | 820.9 Thousand USD | 80.3% |
| 2017 FY | 711.39 Thousand USD | 104.16% |
| 2017 Q1 | 301.81 Thousand USD | -13.39% |
| 2017 Q4 | 711.39 Thousand USD | -13.34% |
| 2016 Q1 | 541.52 Thousand USD | 32.15% |
| 2016 FY | 348.45 Thousand USD | -14.96% |
| 2016 Q2 | 495.57 Thousand USD | -8.49% |
| 2016 Q4 | 348.45 Thousand USD | -39.64% |
| 2016 Q3 | 577.34 Thousand USD | 16.5% |
| 2015 Q4 | 409.77 Thousand USD | -32.74% |
| 2015 Q2 | 524.91 Thousand USD | 52.07% |
| 2015 Q1 | 345.18 Thousand USD | -14.25% |
| 2015 FY | 409.77 Thousand USD | 1.8% |
| 2015 Q3 | 609.23 Thousand USD | 16.06% |
| 2014 FY | 402.53 Thousand USD | 30.9% |
| 2014 Q2 | 500.44 Thousand USD | 30.46% |
| 2014 Q1 | 383.59 Thousand USD | 24.74% |
| 2014 Q4 | 402.53 Thousand USD | -18.23% |
| 2014 Q3 | 492.27 Thousand USD | -1.63% |
| 2013 FY | 307.5 Thousand USD | -32.3% |
| 2013 Q3 | 459.03 Thousand USD | 55.21% |
| 2013 Q4 | 307.5 Thousand USD | -33.01% |
| 2013 Q1 | 326.89 Thousand USD | -28.03% |
| 2013 Q2 | 295.74 Thousand USD | -9.53% |
| 2012 FY | 454.21 Thousand USD | 67.48% |
| 2012 Q2 | 309.73 Thousand USD | -18.73% |
| 2012 Q3 | 566.63 Thousand USD | 82.94% |
| 2012 Q4 | 454.21 Thousand USD | -19.84% |
| 2012 Q1 | 381.1 Thousand USD | 40.52% |
| 2011 Q3 | 412.6 Thousand USD | 38.87% |
| 2011 Q4 | 271.2 Thousand USD | -34.27% |
| 2011 FY | 271.2 Thousand USD | -6.49% |
| 2011 Q2 | 297.12 Thousand USD | -13.1% |
| 2011 Q1 | 341.92 Thousand USD | 17.89% |
| 2010 FY | 290.03 Thousand USD | 121.96% |
| 2010 Q3 | 87.45 Thousand USD | -17.79% |
| 2010 Q4 | 290.03 Thousand USD | 231.66% |
| 2010 Q1 | 130.28 Thousand USD | -0.29% |
| 2010 Q2 | 106.37 Thousand USD | -18.36% |
| 2009 FY | 130.66 Thousand USD | 30.85% |
| 2009 Q4 | 130.66 Thousand USD | 9.29% |
| 2009 Q3 | 119.56 Thousand USD | 87.41% |
| 2009 Q2 | 63.79 Thousand USD | -7.97% |
| 2009 Q1 | 69.32 Thousand USD | -30.58% |
| 2008 Q1 | 248.68 Thousand USD | -5.54% |
| 2008 Q4 | 99.85 Thousand USD | -54.07% |
| 2008 Q3 | 217.41 Thousand USD | -7.22% |
| 2008 Q2 | 234.32 Thousand USD | -5.77% |
| 2008 FY | 99.85 Thousand USD | -62.07% |
| 2007 Q2 | 203.05 Thousand USD | 160.86% |
| 2007 Q3 | 273.06 Thousand USD | 34.48% |
| 2007 FY | 263.27 Thousand USD | 172.62% |
| 2007 Q4 | 263.27 Thousand USD | -3.59% |
| 2007 Q1 | 77.84 Thousand USD | -19.4% |
| 2006 Q1 | 113.6 Thousand USD | 270.73% |
| 2006 Q2 | 101.74 Thousand USD | -10.44% |
| 2006 Q4 | 96.57 Thousand USD | -43.91% |
| 2006 Q3 | 172.16 Thousand USD | 69.21% |
| 2006 FY | 96.57 Thousand USD | 215.14% |
| 2005 Q3 | 82.22 Thousand USD | -5.27% |
| 2005 Q2 | 86.79 Thousand USD | -3.6% |
| 2005 Q4 | 30.64 Thousand USD | -62.73% |
| 2005 FY | 30.64 Thousand USD | -67.84% |
| 2005 Q1 | 90.03 Thousand USD | -5.53% |
| 2004 Q2 | - USD | 0.0% |
| 2004 Q3 | 104.74 Thousand USD | 0.0% |
| 2004 FY | 95.3 Thousand USD | 0.0% |
| 2004 Q4 | 95.3 Thousand USD | -9.02% |
| 2004 Q1 | - USD | 0.0% |
| 2002 Q1 | 131.74 Thousand USD | 0.0% |
| 2001 Q2 | - USD | 0.0% |
| 2001 Q3 | 140 Thousand USD | 0.0% |
| 2001 Q4 | 131.74 Thousand USD | -5.9% |
| 2001 Q1 | - USD | 0.0% |
| 2001 FY | 131.74 Thousand USD | 0.0% |
| 2000 Q4 | - USD | 0.0% |
| 2000 Q1 | - USD | 0.0% |
| 2000 Q3 | - USD | 0.0% |
| 2000 FY | - USD | 0.0% |
| 2000 Q2 | - USD | 0.0% |
| 1999 FY | - USD | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Akoya Biosciences, Inc. | 17.87 Million USD | 73.611% |
| AngioDynamics, Inc. | 60.61 Million USD | 92.217% |
| AtriCure, Inc. | 67.89 Million USD | 93.052% |
| Avinger, Inc. | 5.29 Million USD | 10.956% |
| Azenta, Inc. | 128.19 Million USD | 96.32% |
| BioLife Solutions, Inc. | 43.45 Million USD | 89.144% |
| The Cooper Companies, Inc. | 735.6 Million USD | 99.359% |
| Daxor Corporation | - USD | -Infinity% |
| Ekso Bionics Holdings, Inc. | 5.05 Million USD | 6.584% |
| Femasys Inc. | 667.11 Thousand USD | -607.151% |
| GlucoTrack, Inc. | - USD | -Infinity% |
| Harvard Bioscience, Inc. | 24.71 Million USD | 80.913% |
| Hologic, Inc. | 679.8 Million USD | 99.306% |
| ICU Medical, Inc. | 709.36 Million USD | 99.335% |
| Intuitive Surgical, Inc. | 1.22 Billion USD | 99.614% |
| KORU Medical Systems, Inc. | 3.48 Million USD | -35.511% |
| LeMaitre Vascular, Inc. | 52.33 Million USD | 90.986% |
| Innovative Eyewear, Inc. | 856.75 Thousand USD | -450.625% |
| Innovative Eyewear, Inc. | 856.75 Thousand USD | -450.625% |
| Masimo Corporation | 545 Million USD | 99.134% |
| Microbot Medical Inc. | - USD | -Infinity% |
| Meihua International Medical Technologies Co., Ltd. | 1.61 Million USD | -191.705% |
| Merit Medical Systems, Inc. | 303.87 Million USD | 98.448% |
| Nephros, Inc. | 2.47 Million USD | -90.993% |
| NovoCure Limited | 38.15 Million USD | 87.635% |
| NEXGEL, Inc. | 1.31 Million USD | -257.66% |
| NEXGEL, Inc. | 1.31 Million USD | -257.66% |
| Singular Genomics Systems, Inc. | 13.57 Million USD | 65.241% |
| OraSure Technologies, Inc. | 47.61 Million USD | 90.092% |
| Pro-Dex, Inc. | 15.26 Million USD | 69.104% |
| Pulse Biosciences, Inc. | - USD | -Infinity% |
| Predictive Oncology Inc. | 494.37 Thousand USD | -854.244% |
| Precision Optics Corporation, Inc. | 2.86 Million USD | -64.483% |
| QuidelOrtho Corporation | 577.8 Million USD | 99.184% |
| Repligen Corporation | 202.32 Million USD | 97.668% |
| STAAR Surgical Company | 35.13 Million USD | 86.571% |
| Sharps Technology, Inc. | 1.7 Million USD | -176.019% |
| Utah Medical Products, Inc. | 9.58 Million USD | 50.767% |
| DENTSPLY SIRONA Inc. | 624 Million USD | 99.244% |
| Jin Medical International Ltd. | 5.05 Million USD | 6.641% |